Cyclin-dependent kinases: initial approaches to exploit a novel therapeutic target.
Sausville EA, Zaharevitz D, Gussio R, Meijer L, Louarn-Leost M, Kunick C, Schultz R, Lahusen T, Headlee D, Stinson S, Arbuck SG, Senderowicz A.
Sausville EA, et al.
Pharmacol Ther. 1999 May-Jun;82(2-3):285-92. doi: 10.1016/s0163-7258(98)00062-x.
Pharmacol Ther. 1999.
PMID: 10454206
Review.